Stay Ahead of the Latest Pharma & Biotech Industry News Around Environmental, Social and Governance (ESG)
Boards and top executives are facing a growing focus on Environmental, Social and Governance (ESG), and its impact on public companies. Today’s business professional must be fully informed to articulate a sound ESG strategy in order to attract investors and prepare top executives to successfully answer stakeholder questions about their company’s performance across the ESG spectrum.
We can help. Cision’s new ESG in Pharma & Biotech Update delivers critical news on ESG developments in your industry straight to your inbox. With a daily review of ESG news from your competitors, regulatory agencies, and industry partners you and your executives will avoid surprises and gain the actionable insights needed to capitalize on opportunities in this fast-developing area.
Register today to receive:
- A free two-week trial of our new ESG in Pharma & Biotech Update, featuring the top headlines and stories from across the US, curated and custom-written by the same team of expert media analysts that write the daily briefing for HHS, the FDA, and many healthcare clients.
- The morning briefing delivered daily directly to your inbox by 8am ET.
- A weekly look at Cision Insights’ exclusive quantitative analysis of ESG coverage related to the healthcare industry.
Request a meeting to meet with one of our experts to discuss your ESG reporting needs.